Immunoassays

This protocol details the procedure for testing samples with the OLM Aspergillus LFD (AspLFD). The following protocol is summarised in the figure overleaf. Please see the AspLFD handbook for more detailed product information.

The PhoenixDx® SARS-CoV-2 Neutralizing Antibody Test Kit (ELISA) is used for the in vitro qualitative detection of neutralizing antibodies (nAb) against RBD of Novel Coronavirus (SARS-CoV-2) S1 protein in human serum or plasma.

real-time RT-PCR-based diagnostic test for the in vitro qualitative detection and discrimination of SARS-CoV-2, Delta and Omicron.

The Avidity Cytomegalovirus (CMV) IgG ELISA is intended to indicate the CMV-specific IgG avidity in human serum or plasma (citrate, heparin) to differentiate between acute and past infection.

The Avidity Epstein-Barr Virus (VCA) IgG ELISA is intended to indicate the Epstein-Barr virus viral capsid antigen (VCA)-specific IgG avidity in human serum or plasma (citrate, heparin) to differentiate between acute and past infection.

The Avidity Measles Virus IgG ELISA is intended to indicate the Measles-specific IgG avidity in human serum or plasma (citrate, heparin) to differentiate between acute and past infection.

The Avidity Rubella Virus IgG ELISA is intended to indicate the Rubella-specific IgG avidity in human serum or plasma (citrate, heparin) to differentiate between acute and past infection.